BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31412168)

  • 1. Solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the qualitative analysis of 61 synthetic cannabinoid metabolites in urine.
    Gaunitz F; Kieliba T; Thevis M; Mercer-Chalmers-Bender K
    Drug Test Anal; 2020 Jan; 12(1):27-40. PubMed ID: 31412168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatography-tandem mass spectrometry screening method using information-dependent acquisition of enhanced product ion mass spectra for synthetic cannabinoids including metabolites in urine.
    Staeheli SN; Veloso VP; Bovens M; Bissig C; Kraemer T; Poetzsch M
    Drug Test Anal; 2019 Sep; 11(9):1369-1376. PubMed ID: 31219237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.
    Scheidweiler KB; Jarvis MJ; Huestis MA
    Anal Bioanal Chem; 2015 Jan; 407(3):883-97. PubMed ID: 25224637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of a selection of synthetic cannabinoids and metabolites in urine by UHPSFC-MS/MS and by UHPLC-MS/MS.
    Berg T; Kaur L; Risnes A; Havig SM; Karinen R
    Drug Test Anal; 2016 Jul; 8(7):708-22. PubMed ID: 26304456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-class analysis of new psychoactive substances and metabolites in hair by pressurized liquid extraction coupled to HPLC-HRMS.
    Montesano C; Vannutelli G; Massa M; Simeoni MC; Gregori A; Ripani L; Compagnone D; Curini R; Sergi M
    Drug Test Anal; 2017 May; 9(5):798-807. PubMed ID: 27448433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous quantification of major cannabinoids and metabolites in human urine and plasma by HPLC-MS/MS and enzyme-alkaline hydrolysis.
    Aizpurua-Olaizola O; Zarandona I; Ortiz L; Navarro P; Etxebarria N; Usobiaga A
    Drug Test Anal; 2017 Apr; 9(4):626-633. PubMed ID: 27341312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening, quantification, and confirmation of synthetic cannabinoid metabolites in urine by UHPLC-QTOF-MS.
    Gundersen POM; Spigset O; Josefsson M
    Drug Test Anal; 2019 Jan; 11(1):51-67. PubMed ID: 29996011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of 74 new psychoactive substances in serum using automated in-line solid-phase extraction-liquid chromatography-tandem mass spectrometry.
    Lehmann S; Kieliba T; Beike J; Thevis M; Mercer-Chalmers-Bender K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Oct; 1064():124-138. PubMed ID: 28922649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.
    Vikingsson S; Gréen H; Brinkhagen L; Mukhtar S; Josefsson M
    Drug Test Anal; 2016 Sep; 8(9):950-6. PubMed ID: 26560240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
    Yeter O; Ozturk YE
    Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous quantification of 20 synthetic cannabinoids and 21 metabolites, and semi-quantification of 12 alkyl hydroxy metabolites in human urine by liquid chromatography-tandem mass spectrometry.
    Scheidweiler KB; Huestis MA
    J Chromatogr A; 2014 Jan; 1327():105-17. PubMed ID: 24418231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018.
    Ong RS; Kappatos DC; Russell SGG; Poulsen HA; Banister SD; Gerona RR; Glass M; Johnson CS; McCarthy MJ
    Drug Test Anal; 2020 Feb; 12(2):195-214. PubMed ID: 31595682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of new psychoactive substances in oral fluids by means of microextraction by packed sorbent followed by ultra-high-performance liquid chromatography-tandem mass spectrometry.
    Rocchi R; Simeoni MC; Montesano C; Vannutelli G; Curini R; Sergi M; Compagnone D
    Drug Test Anal; 2018 May; 10(5):865-873. PubMed ID: 29078252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens.
    Haschimi B; Mogler L; Halter S; Giorgetti A; Schwarze B; Westphal F; Fischmann S; Auwärter V
    Drug Test Anal; 2019 Sep; 11(9):1377-1386. PubMed ID: 31228224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Fast and Comprehensive Analysis of 32 Synthetic Cannabinoids Using Agilent Triple Quadrupole LC-MS-MS.
    Borg D; Tverdovsky A; Stripp R
    J Anal Toxicol; 2017 Jan; 41(1):6-16. PubMed ID: 27681343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS.
    Hutter M; Broecker S; Kneisel S; Franz F; Brandt SD; Auwarter V
    Curr Pharm Biotechnol; 2018; 19(2):144-162. PubMed ID: 29745330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of over 100 drugs in horse urine using automated on-line solid-phase extraction coupled to liquid chromatography-high resolution mass spectrometry for doping control.
    Kwok WH; Choi TLS; Tsoi YYK; Leung GNW; Wan TSM
    J Chromatogr A; 2017 Mar; 1490():89-101. PubMed ID: 28215405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a micro-solid-phase extraction molecularly imprinted polymer technique for synthetic cannabinoids assessment in urine followed by liquid chromatography-tandem mass spectrometry.
    Sánchez-González J; Odoardi S; Bermejo AM; Bermejo-Barrera P; Romolo FS; Moreda-Piñeiro A; Strano-Rossi S
    J Chromatogr A; 2018 May; 1550():8-20. PubMed ID: 29605179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of major phytocannabinoids, their main metabolites, and common synthetic cannabinoids in urine samples by LC-MS/MS.
    Dong X; Li L; Ye Y; Zheng L; Jiang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():55-64. PubMed ID: 27521533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens.
    Castaneto MS; Scheidweiler KB; Gandhi A; Wohlfarth A; Klette KL; Martin TM; Huestis MA
    Drug Test Anal; 2015 Jun; 7(6):483-93. PubMed ID: 25231213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.